128 related articles for article (PubMed ID: 90788)
21. [Treatment of leukemias and lymphomas with interferons: I. Trial of myeloma therapy with human beta-interferon].
Misset JL; Mathé G; Gastiaburu J; Goutner A; Dorval T; Gouveia J; Hayat M; Jasmin C; Schwarzenburg L; Machover D; Ribaud P; De Vassal F; Horosezewicz JS
Biomed Pharmacother; 1982 Jan; 36(1):55-9. PubMed ID: 6181822
[TBL] [Abstract][Full Text] [Related]
22. Myeloma (multiple).
Kumar A; Djulbegovic B
Clin Evid; 2006 Jun; (15):1-29. PubMed ID: 16973003
[No Abstract] [Full Text] [Related]
23. Interferon: anticancer agent having multifarious activity.
Yabrov AA
Prog Clin Cancer; 1982; 8():99-145. PubMed ID: 6185970
[No Abstract] [Full Text] [Related]
24. Clinical and immunological studies of human fibroblast interferon.
Ezaki K; Ogawa M; Okabe K; Abe K; Inoue K; Horikoshi N; Inagaki J
Cancer Chemother Pharmacol; 1982; 8(1):47-55. PubMed ID: 6178525
[No Abstract] [Full Text] [Related]
25. Biotherapy with interferon in hematologic malignancies.
Roth MS; Foon KA
Oncol Nurs Forum; 1987; 14(6 Suppl):16-22. PubMed ID: 2447569
[No Abstract] [Full Text] [Related]
26. [New therapeutic approaches in multiple myeloma].
Harousseau JL
Ann Med Interne (Paris); 1989; 140(1):45-9. PubMed ID: 2472083
[No Abstract] [Full Text] [Related]
27. Therapeutic strategies and controversies in the treatment of multiple myeloma.
Bladé J
Pathol Biol (Paris); 1999 Feb; 47(2):192-8. PubMed ID: 10192888
[TBL] [Abstract][Full Text] [Related]
28. Supportive therapies in the management of myeloma.
Ludwig H;
Oncology (Williston Park); 2004 Mar; 18(3):295-6, 298. PubMed ID: 15065700
[No Abstract] [Full Text] [Related]
29. Interferons: in pursuit of the promise.
Borden EC
Prog Clin Biol Res; 1983; 132E():287-96. PubMed ID: 6196788
[No Abstract] [Full Text] [Related]
30. [Interferons: Clinical applications in hematology].
Ben Rhomdhane N; Ben Ahmed M; Zitouni M; Mtimet B
Tunis Med; 1998 Dec; 76(12):427-36. PubMed ID: 10093482
[No Abstract] [Full Text] [Related]
31. [Immunotherapy of mice bearing myeloma and EL4 leukemia].
Kitasato M
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):958-65. PubMed ID: 2447213
[No Abstract] [Full Text] [Related]
32. Interferon therapy in cancer: from imaginon to interferon.
Goldstein D; Laszlo J
Cancer Res; 1986 Sep; 46(9):4315-29. PubMed ID: 2425950
[No Abstract] [Full Text] [Related]
33. [Interferon therapy in hematologic neoplasms].
Schwarzinger I; Bettelheim P; Lechner K
Wien Klin Wochenschr; 1988 Aug; 100(15):497-504. PubMed ID: 2459854
[TBL] [Abstract][Full Text] [Related]
34. Multiple myeloma. Part II: Treatment.
Varet B; Choukroun G; Grünfeld JP
Nephron; 1995; 70(1):18-20. PubMed ID: 7542366
[No Abstract] [Full Text] [Related]
35. Interferons as antitumor agents.
Taylor S
J Kans Med Soc; 1981 Mar; 82(3):128-30, 138. PubMed ID: 6168716
[No Abstract] [Full Text] [Related]
36. [Development and current perspectives of treatment in multiple myeloma].
Sanz Marca A; López Alvarez J; Aboin Massieu FJ
Rev Clin Esp; 1983 Nov; 171(3):225-9. PubMed ID: 6199817
[No Abstract] [Full Text] [Related]
37. [Multiple myeloma].
Kawanishi K; Kanamaru A
Ryoikibetsu Shokogun Shirizu; 2000; (32):413-7. PubMed ID: 11212761
[No Abstract] [Full Text] [Related]
38. [Current therapy concepts in patients with multiple myeloma].
Heyll A; Schneider P; Bauser U; Kobbe G; Hünerlitürkoglu A; Aul C; Haas R
Dtsch Med Wochenschr; 2000 Oct; 125(40):1201-9. PubMed ID: 11075253
[No Abstract] [Full Text] [Related]
39. Possible synergism between cimetidine and interferon in a case of resistant multiple myeloma.
Osby E; Bernell P; Hast R
Eur J Haematol; 1987 Jul; 39(1):86-7. PubMed ID: 2443386
[No Abstract] [Full Text] [Related]
40. [Physiopathology, diagnosis and therapy in multiple myeloma (discussion)].
Nihon Naika Gakkai Zasshi; 1995 Jul; 84(7):1132-49. PubMed ID: 7561372
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
